1. Molecular docking, synthesis, and biological evaluation of 7-azaindole-derivative (7AID) as novel anti-cancer agent and potent DDX3 inhibitor:—an in silico and in vitro approach

   • Ravinder Doneti
   • Akbar Pasha
   • Smita C. Pawar

   Original Paper 01 September 2022 Article: 179

   

2. Decoding the mechanism of vascular morphogenesis to explore future prospects in targeted tumor therapy

   • Gayathri Venkatakrishnan
   • Venkatachalam Deepa Parvathi

   Review Article 29 August 2022 Article: 178

   

3. Isolation and characterization of human anti-CD20 single-chain variable fragment (scFv) from a Naive human scFv library

   • Nasir Shams
   • Shahryar Khoshtinat Nikkhoi
   • Fatemeh Rahbarizadeh

   Original Paper 23 August 2022 Article: 177

   

4. Assessment of mechanism involved in the apoptotic and anti-cancer activity of Quercetin and Quercetin-loaded chitosan nanoparticles

   • Murat Dogan

   Original Paper 23 August 2022 Article: 176

   

5. CRISPR/Cas9-mediated knockout of HO-1 decreased the proliferation and migration of T47D cells and increased cisplatin-induced apoptosis: an in vitro study

   • Sahar Evazi Bakhshi
   • Amaneh Mohammadi Roushandeh
   • Mohammad Hadi Bahadori

   Original Paper 16 August 2022 Article: 175

   

6. Clinical value and molecular mechanism of AQGPs in different tumors

   • Rui Wang
   • Xuejian Wang
   • Jianbo Wang

   Review Article Open access 16 August 2022 Article: 174

   

7. RNA splicing: a dual-edged sword for hepatocellular carcinoma

   • Anjali Kashyap
   • Greesham Tripathi
   • Manoj Kumar Kashyap

   Review Article 16 August 2022 Article: 173

   

8. Synthesis, characterization, antioxidant and anticancer activities of a new Schiff base and its M(II) complexes derived from 5-fluorouracil

   • Ahmet Savcı
   • Kenan Buldurun
   • Nevin Turan

   Original Paper 16 August 2022 Article: 172

   

9. Differential molecular mechanistic behavior of HDACs in cancer progression

   • Tashvinder Singh
   • Prabhsimran Kaur
   • Anjana Munshi

   Review Article 16 August 2022 Article: 171

   

10. The inhibitory effect of betulinic acid on epithelial–mesenchymal transition pathway in renal cell carcinoma

    • Merve Nur Ataş
    • Barış Ertuğrul
    • Arzu Ergen

    Original Paper 16 August 2022 Article: 170

    

11. SND1 confers chemoresistance to cisplatin-induced apoptosis by targeting GAS6-AKT in SKOV3 ovarian cancer cells

    • Chuanbo Ha
    • Lihong Hu
    • Lingbiao Xin

    Original Paper 16 August 2022 Article: 169

    

12. Pancreatic adenocarcinoma and pancreatic high-grade neuroendocrine carcinoma: two sides of the moon

    • Anna La Salvia
    • Irene Persano
    • Maria Pia Brizzi

    Review Article 16 August 2022 Article: 168

    

13. Matrine induces autophagy in human neuroblastoma cells via blocking the AKT-mTOR pathway

    • Nanjing Liu
    • Chunmei Yang
    • Xiaoyan He

    Original Paper Open access 16 August 2022 Article: 167

    

14. Chk1/2 inhibitor AZD7762 enhances the susceptibility of IDH-mutant brain cancer cells to temozolomide

    • Erkin Ozgiray
    • Fatma Sogutlu
    • Cigir Biray Avci

    Original Paper 16 August 2022 Article: 166

    

15. Alpha7 nicotinic acetylcholine receptor expression in Sorafenib-resistant Hepatocellular carcinoma cells

    • Mina Afrashteh Nour
    • Fatemeh Kheradmand
    • Behzad Baradaran

    Original Paper 16 August 2022 Article: 165

    

16. Genetic insights into cardiac tumors: a comprehensive review

    • Sivaramasundaram Sankarasubramanian
    • Prathiksha Prabhakar
    • Manoj Kumar Narasimhan

    Review Article 16 August 2022 Article: 164

    

17. Phase II study of S-1 and irinotecan combination therapy in EGFR-mutated non-small cell lung cancer resistant to epidermal growth factor receptor tyrosine kinase inhibitor: North Japan Lung Cancer Study Group Trial 0804 (NJLCG0804)

    • Atsushi Nakamura
    • Masao Harada
    • Shunichi Sugawara

    Original Paper 16 August 2022 Article: 163

    

18. A novel approach to develop an animal model for oral submucous fibrosis

    • Madhura Shekatkar
    • Supriya Kheur
    • Ramesh Bhonde

    Original Paper 16 August 2022 Article: 162

    

19. MiR-210-3p targets CELF2 to facilitate progression of lung squamous carcinoma through PI3K/AKT pathway

    • Qiang Zhang
    • Yunzhen Wang

    Original Paper 16 August 2022 Article: 161

    

20. Origin and evolution of animal multicellularity in the light of phylogenomics and cancer genetics

    • Florian Jacques
    • Etienne Baratchart
    • Emma U. Hammarlund

    Perspectives in Oncology Open access 16 August 2022 Article: 160

    

21. Regulation of the sensitivity of hepatocarcinoma cells by ORMDL3, to sorafenib by autophagy

    • Yixiao Sun
    • Xueran Guan
    • Lin Cai

    Original Paper Open access 16 August 2022 Article: 159